Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trialJohann S. de Bono, Ulrik Lassen, Emma Dean et al.|The Lancet Oncology|2019Cited by 228
First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignanciesSandra Irenaeus, Gustav Ullenhag, Adnan Deronic et al.|International Journal of Cancer|2019Cited by 142